Enzo Biochem, Inc. (ENZ) Reports Q3 Loss of $0.09/Share

Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $26 million, versus $25.8 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• Arena Group to rename as Paradium.AI, ticker changing to PAAI